Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Stock News
09/29

Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration Certificate of the People's Republic of China issued by the Chongqing Medical Products Administration for its product, the Photon Therapeutic Apparatus.

The registered Photon Therapeutic Apparatus is capable of emitting high-energy narrow-spectrum red light and blue light, and supports multiple treatment modes to meet the therapeutic needs of different users.

The product is suitable for patients requiring anti-inflammatory and analgesic treatment, as well as those needing to stop exudate from superficial wounds, promote granulation tissue growth, and accelerate wound healing. It can be used in a variety of settings including hospital departments, clinics, and homes.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10